<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mimmun</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская иммунология</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Immunology (Russia)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1563-0625</issn><issn pub-type="epub">2313-741X</issn><publisher><publisher-name>SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15789/1563-0625-2009-1-21-28</article-id><article-id custom-type="elpub" pub-id-type="custom">mimmun-37</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>ПОЛИМОРФИЗМ ПРОМОТОРНОГО РЕГИОНА ГЕНОВ IL-4, IL-6 И IL-10 У ПАЦИЕНТОК С РАКОМ МОЛОЧНОЙ ЖЕЛЕЗЫ</article-title><trans-title-group xml:lang="en"><trans-title>PROMOTOR POLYMORPHISM OF IL-4, IL-6, AND IL-10 GENES AMONG PATIENTS WITH BREAST CANCER</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шевченко</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Shevchenko</surname><given-names>A. V.</given-names></name></name-alternatives><email xlink:type="simple">shalla64@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Голованова</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Golovanova</surname><given-names>O. V.</given-names></name></name-alternatives><email xlink:type="simple">shalla64@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Коломейчук</surname><given-names>М. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Kolomejtchuk</surname><given-names>M. Ju.</given-names></name></name-alternatives><email xlink:type="simple">shalla64@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Коненков</surname><given-names>В. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Konenkov</surname><given-names>V. I.</given-names></name></name-alternatives><email xlink:type="simple">shalla64@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гарбуков</surname><given-names>Е. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Garbukov</surname><given-names>E. Ju.</given-names></name></name-alternatives><email xlink:type="simple">shalla64@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Стахеева</surname><given-names>М. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Stakheeva</surname><given-names>M. N.</given-names></name></name-alternatives><email xlink:type="simple">shalla64@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>ГУ НИИ клинической и экспериментальной лимфологии СО РАМН, г. Новосибирск</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-2"><institution>ГУ НИИ онкологии Томского научного центра СО РАМН</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>08</day><month>07</month><year>2014</year></pub-date><volume>11</volume><issue>1</issue><fpage>21</fpage><lpage>28</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Шевченко А.В., Голованова О.В., Коломейчук М.Ю., Коненков В.И., Гарбуков Е.Ю., Стахеева М.Н., 2014</copyright-statement><copyright-year>2014</copyright-year><copyright-holder xml:lang="ru">Шевченко А.В., Голованова О.В., Коломейчук М.Ю., Коненков В.И., Гарбуков Е.Ю., Стахеева М.Н.</copyright-holder><copyright-holder xml:lang="en">Shevchenko A.V., Golovanova O.V., Kolomejtchuk M.J., Konenkov V.I., Garbukov E.J., Stakheeva M.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.mimmun.ru/mimmun/article/view/37">https://www.mimmun.ru/mimmun/article/view/37</self-uri><abstract><p>Несмотря на то что современные представления о роли цитокинов как регуляторов иммунного ответа при опухолевой патологии крайне противоречивы, их роль в процессе онкогенеза не подвергается сомнению. Поскольку регуляция экспрессии цитокинов происходит прежде всего на транскрипционном уровне, в промоторном регионе гена, нами впервые проведен анализ распределения частот генотипов промоторного региона генов IL-4, IL-6 и IL-10 в группе здоровых женщин и больных РМЖ. Выявлены особенности их распределения в группе с патологией относительно здоровых женщин, в группах с наследственной онкоотягощенностью, в том числе c РМЖ в семейном анамнезе у предыдущих поколений (бабушка, мама) либо у сестер.</p></abstract><trans-abstract xml:lang="en"><p>In spite of extreme controversies on possible role of cytokines as regulating factors in cancer pathology, their role during carcinogenesis is beyond doubts. Since regulation of cytokine gene expression is known to proceed, mainly, at the level of transcription, from promoter region, we have undertaken an analysis of genotypic frequencies in promoter regions of IL-4, IL-6 and IL-10 genes for a group of relatively healthy women and patients with breast cancer. Some specific features of allelic distribution have been found in groups of healthy women, among cohorts with hereditary predisposition, including the patients with breast cancer who had clustering of the disease in families (i.e., mother, grandmother, or sister been affected).</p></trans-abstract><kwd-group xml:lang="ru"><kwd>рак молочной железы</kwd><kwd>полиморфизм</kwd><kwd>IL-4</kwd><kwd>IL-6</kwd><kwd>IL-10</kwd></kwd-group><kwd-group xml:lang="en"><kwd>breast cancer</kwd><kwd>polymorphism</kwd><kwd>IL-4</kwd><kwd>IL-6</kwd><kwd>IL-10</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Бабышкина Н.Н., Стахеева М.Н., Слонимская Е.М., Чердынцева Н.В., Гарбуков Е.Ю. Иммунологические параметры и уровень продукции цитокинов у больных с пролиферативными заболеваниями и раком молочной железы//Цитокины и воспаление. -2006 -Т. 5, №1. -С. 37-43.</mixed-citation><mixed-citation xml:lang="en">Бабышкина Н.Н., Стахеева М.Н., Слонимская Е.М., Чердынцева Н.В., Гарбуков Е.Ю. Иммунологические параметры и уровень продукции цитокинов у больных с пролиферативными заболеваниями и раком молочной железы//Цитокины и воспаление. -2006 -Т. 5, №1. -С. 37-43.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Литовкин К.В., Доменюк В.П., Бубнов В.В., Запорожан В.Н. Полиморфизм -174G/C в промоторе гена IL-6 у больных раком молочной железы и миомой матки: популяционный анализ на основе сравнения контрольной и опытных групп -http://www.exp-oncology.com.ua/ru/archives/33/650.html.</mixed-citation><mixed-citation xml:lang="en">Литовкин К.В., Доменюк В.П., Бубнов В.В., Запорожан В.Н. Полиморфизм -174G/C в промоторе гена IL-6 у больных раком молочной железы и миомой матки: популяционный анализ на основе сравнения контрольной и опытных групп -http://www.exp-oncology.com.ua/ru/archives/33/650.html.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Родионов С.Ю., Черешнев В.А., Орлова Е.Г., Тараненко Л.А., Сибиряк С.В., Орлов О.А., Шур Н.Н., Крапивина О.А., Суховая Д.А. Содержание сывороточных цитокинов у онкологических больных при иммуно-и полихимиотерапии с применением альфа-фетопротеина человека//Цитокины и воспаление. -2007.-Т. 6, № 3. -С. 36-39.</mixed-citation><mixed-citation xml:lang="en">Родионов С.Ю., Черешнев В.А., Орлова Е.Г., Тараненко Л.А., Сибиряк С.В., Орлов О.А., Шур Н.Н., Крапивина О.А., Суховая Д.А. Содержание сывороточных цитокинов у онкологических больных при иммуно-и полихимиотерапии с применением альфа-фетопротеина человека//Цитокины и воспаление. -2007.-Т. 6, № 3. -С. 36-39.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Тугуз А.Р., Анисимова Н.Ю., Вершинина М.В. Соотношение основных цитокинов в крови онкологических больных и здоровых доноров//Иммунология. -2003. -Т. 3. -С. 184-186.</mixed-citation><mixed-citation xml:lang="en">Тугуз А.Р., Анисимова Н.Ю., Вершинина М.В. Соотношение основных цитокинов в крови онкологических больных и здоровых доноров//Иммунология. -2003. -Т. 3. -С. 184-186.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Чердынцева Н.В., Перельмутер В.М., Слонимская Е.М., Литвяков Н.В., Стахеева М.Н., Гарбуков Е.Ю., Завьялова М.В., Глущенко С.А., Малиновская Е.А., Дорошенко А.В., Красулина Н.А. Молекулярно-генетические факторы прогрессии как критерии прогноза у больных со злокачественными новообразованиями молочной железы//Российский Онкологический Портал. X Российский онкологический конгресс. -М., 2006.</mixed-citation><mixed-citation xml:lang="en">Чердынцева Н.В., Перельмутер В.М., Слонимская Е.М., Литвяков Н.В., Стахеева М.Н., Гарбуков Е.Ю., Завьялова М.В., Глущенко С.А., Малиновская Е.А., Дорошенко А.В., Красулина Н.А. Молекулярно-генетические факторы прогрессии как критерии прогноза у больных со злокачественными новообразованиями молочной железы//Российский Онкологический Портал. X Российский онкологический конгресс. -М., 2006.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Balasubramanian S.P., Azmy I.A.F., Higham S.E., Wilson A.G., Cross S.S., Cox A., Brown N., Reed M.W. Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review//BMC Cancer. -2006. -Vol. 188, N 6. -http://www.biomedcentral.com/1471-2407/6/188 &lt;http://www.biomedcentral.com/1471-2407/6/188&gt;.</mixed-citation><mixed-citation xml:lang="en">Balasubramanian S.P., Azmy I.A.F., Higham S.E., Wilson A.G., Cross S.S., Cox A., Brown N., Reed M.W. Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review//BMC Cancer. -2006. -Vol. 188, N 6. -http://www.biomedcentral.com/1471-2407/6/188 &lt;http://www.biomedcentral.com/1471-2407/6/188&gt;.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Bland J.M., Altman D.G. Education and debate. The odds ratio//BMJ. -2000. -Vol. 320. -P. 1468.</mixed-citation><mixed-citation xml:lang="en">Bland J.M., Altman D.G. Education and debate. The odds ratio//BMJ. -2000. -Vol. 320. -P. 1468.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Brower V. Researchers Attempting To Define Role of Cytokines in Cancer Risk//Journal of the National Cancer Institute. -2005. -Vol. 97, N 16. -P. 1175-1177.</mixed-citation><mixed-citation xml:lang="en">Brower V. Researchers Attempting To Define Role of Cytokines in Cancer Risk//Journal of the National Cancer Institute. -2005. -Vol. 97, N 16. -P. 1175-1177.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Cantagrel A., Navaux F., Loubet-Lessonlie P. IL-1beta, IL-1 receptor antagonist, IL-4, and IL-10 gene polymorphisms//Arthr Rheum. -1999.-Vol. 42, N 6. -P. 1093-1100.</mixed-citation><mixed-citation xml:lang="en">Cantagrel A., Navaux F., Loubet-Lessonlie P. IL-1beta, IL-1 receptor antagonist, IL-4, and IL-10 gene polymorphisms//Arthr Rheum. -1999.-Vol. 42, N 6. -P. 1093-1100.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Caruso C., Lio D., Cavallone L., Franceschi C. Aging, Longevity, Inflammation, and Cancer//Ann. N.Y. Acad. Sci. -2004. -Vol. 1028. -P. 1-13.</mixed-citation><mixed-citation xml:lang="en">Caruso C., Lio D., Cavallone L., Franceschi C. Aging, Longevity, Inflammation, and Cancer//Ann. N.Y. Acad. Sci. -2004. -Vol. 1028. -P. 1-13.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Choi E., Lee H.J., Yoo T., Chanock S.A. Common haplotype of interleukin-4 gene IL-4 is associated with severe respiratory syncytial virus disease in Korean children//The Journal of Infectious Diseases.-2002. -Vol. 186. -P. 1207-1211.</mixed-citation><mixed-citation xml:lang="en">Choi E., Lee H.J., Yoo T., Chanock S.A. Common haplotype of interleukin-4 gene IL-4 is associated with severe respiratory syncytial virus disease in Korean children//The Journal of Infectious Diseases.-2002. -Vol. 186. -P. 1207-1211.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Conze D., Weiss L., Regen P.S., Bhushan A., Weaver D., Johnson P., Rincon M. Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells//Cancer Res. -2001. -Vol. 61. -P. 8851-8858.</mixed-citation><mixed-citation xml:lang="en">Conze D., Weiss L., Regen P.S., Bhushan A., Weaver D., Johnson P., Rincon M. Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells//Cancer Res. -2001. -Vol. 61. -P. 8851-8858.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">DeMichele A., Martin A.M., Mick R., Gor P., Wray L., Klein-Cabral M., Athanasiadis G., Colligan T.,S tadtmauer E., Weber B. Interleukin-6 (IL-6) -174G/C gene polymorphism and outcome after high dose chemotherapy (HDC) and autologous peripheral stem cell transplant (PSCT) for high risk breast cancer//Proc. Am. Soc. Clin. Oncol. -2002. -Vol. 21. -P. 170.</mixed-citation><mixed-citation xml:lang="en">DeMichele A., Martin A.M., Mick R., Gor P., Wray L., Klein-Cabral M., Athanasiadis G., Colligan T.,S tadtmauer E., Weber B. Interleukin-6 (IL-6) -174G/C gene polymorphism and outcome after high dose chemotherapy (HDC) and autologous peripheral stem cell transplant (PSCT) for high risk breast cancer//Proc. Am. Soc. Clin. Oncol. -2002. -Vol. 21. -P. 170.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">DeMichele A., Martin A.-M., Mick R., Gor P., Wray L., Klein-Cabra M., Athanasiadis G., Colligan T.,Stadtmauer E., Weber B. Interleukin-6 -174G→C polymorphism is associated with improved outcome in high-risk breast cancer//Cancer Res. -2003. -Vol. 63, N 22. -P. 8051-8056.</mixed-citation><mixed-citation xml:lang="en">DeMichele A., Martin A.-M., Mick R., Gor P., Wray L., Klein-Cabra M., Athanasiadis G., Colligan T.,Stadtmauer E., Weber B. Interleukin-6 -174G→C polymorphism is associated with improved outcome in high-risk breast cancer//Cancer Res. -2003. -Vol. 63, N 22. -P. 8051-8056.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">DeMichele A.D., Martin A.-M., Weber B.L. IL-6 variants as modifiers of breast cancer outcome//Proc. Amer. Assoc. Cancer Res. -2004. -Vol. 45. -P. 1316-1317.</mixed-citation><mixed-citation xml:lang="en">DeMichele A.D., Martin A.-M., Weber B.L. IL-6 variants as modifiers of breast cancer outcome//Proc. Amer. Assoc. Cancer Res. -2004. -Vol. 45. -P. 1316-1317.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Fernandez-Real J.-M., Vendrell J., Richart C., Gutierrez C., Ricart W. Platelet count and Interleukin 6 Gene polymorphism in healthy subjects//BMC Medical Genetics. -2001. -Vol. 2(6). -&lt;http://www.biomedcentral.com/1471-2350/2/6&gt;.</mixed-citation><mixed-citation xml:lang="en">Fernandez-Real J.-M., Vendrell J., Richart C., Gutierrez C., Ricart W. Platelet count and Interleukin 6 Gene polymorphism in healthy subjects//BMC Medical Genetics. -2001. -Vol. 2(6). -&lt;http://www.biomedcentral.com/1471-2350/2/6&gt;.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Gоосh J.L., Lee A.V., Yee D. Interleukin-4 inhibits growth and induces apoptosis in human breast cancer cells//Cancer research.-1998. -Vol. 58. -P. 4199-4205.</mixed-citation><mixed-citation xml:lang="en">Gоосh J.L., Lee A.V., Yee D. Interleukin-4 inhibits growth and induces apoptosis in human breast cancer cells//Cancer research.-1998. -Vol. 58. -P. 4199-4205.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Guzowski D., Chandrasekaran A., Gawel C., Palma J., Koenig J., Ping Wang X., Dosik M.,Kaplan M.,Chu C.C., Chavan S., Furie R.,Albesiano E., Chiorazzi N., Goodwin L. Analysis of Single Nucleotide Polymorphisms in the Promoter Region of Interleukin-10 by Denaturing HighPerformance Liquid Chromatography//Journal of Biomolecular Techniques. -2005. -Vol. 16. -P. 154-166.</mixed-citation><mixed-citation xml:lang="en">Guzowski D., Chandrasekaran A., Gawel C., Palma J., Koenig J., Ping Wang X., Dosik M.,Kaplan M.,Chu C.C., Chavan S., Furie R.,Albesiano E., Chiorazzi N., Goodwin L. Analysis of Single Nucleotide Polymorphisms in the Promoter Region of Interleukin-10 by Denaturing HighPerformance Liquid Chromatography//Journal of Biomolecular Techniques. -2005. -Vol. 16. -P. 154-166.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Heneghan M.A., Johnson P.J., Clare M., Ho S., Harrison P.M., Donaldson P.T. Frequency and nature of cytokine gene polymorphisms in hepatocellular carcinoma in Hong Kong Chinese//Int. J. Gastrointest Cancer. -2003. -Vol. 34, N 1. -P. 19-26.</mixed-citation><mixed-citation xml:lang="en">Heneghan M.A., Johnson P.J., Clare M., Ho S., Harrison P.M., Donaldson P.T. Frequency and nature of cytokine gene polymorphisms in hepatocellular carcinoma in Hong Kong Chinese//Int. J. Gastrointest Cancer. -2003. -Vol. 34, N 1. -P. 19-26.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Howell W.M., Rose-Zerilli M.J. Cytokine Gene Polymorphisms, Cancer Susceptibility, and Prognosis//National Blood J. Nutr. -2007. -Vol. 137. -P. 194-199.</mixed-citation><mixed-citation xml:lang="en">Howell W.M., Rose-Zerilli M.J. Cytokine Gene Polymorphisms, Cancer Susceptibility, and Prognosis//National Blood J. Nutr. -2007. -Vol. 137. -P. 194-199.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Hsieh Y.Y., Chang C.C., Tsai C.H., Lin C.C.,Tsai F.J. Interleukin (IL)-12 receptor beta1 codon 378 G homozygote and allele, but not IL-1 (beta-511 promoter, 3953 exon 5, receptor antagonist), IL-2 14, IL-4-590 intron 3, IL-8 3'-UTR 2767, and IL-18 105, are associated with higher susceptibility to leiomyoma//Fertil Steril. -2007. -Vol. 87 (4), -P. 886-895.</mixed-citation><mixed-citation xml:lang="en">Hsieh Y.Y., Chang C.C., Tsai C.H., Lin C.C.,Tsai F.J. Interleukin (IL)-12 receptor beta1 codon 378 G homozygote and allele, but not IL-1 (beta-511 promoter, 3953 exon 5, receptor antagonist), IL-2 14, IL-4-590 intron 3, IL-8 3'-UTR 2767, and IL-18 105, are associated with higher susceptibility to leiomyoma//Fertil Steril. -2007. -Vol. 87 (4), -P. 886-895.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Kleinrath T., Gassner C., Lackner P., Thurnher M., Ramoner R. Interleukin-4 promoter polymorphisms: a genetic prognostic factor for survival in metastatic renal cell carcinoma//J. Clin. Oncol.-2007.-Vol. 25, N 7. -P. 845-851.</mixed-citation><mixed-citation xml:lang="en">Kleinrath T., Gassner C., Lackner P., Thurnher M., Ramoner R. Interleukin-4 promoter polymorphisms: a genetic prognostic factor for survival in metastatic renal cell carcinoma//J. Clin. Oncol.-2007.-Vol. 25, N 7. -P. 845-851.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Kundu N., Beaty T.L., Jackson M.J., Fulton A.M. Antimetastatic and antitumor activities of interleukin 10 in a murine model of breast cancer//J. Natl. Cancer Inst. -1996. -Vol. 88, N 8. -P. 536-541.</mixed-citation><mixed-citation xml:lang="en">Kundu N., Beaty T.L., Jackson M.J., Fulton A.M. Antimetastatic and antitumor activities of interleukin 10 in a murine model of breast cancer//J. Natl. Cancer Inst. -1996. -Vol. 88, N 8. -P. 536-541.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Langsenlehner U., Kriрl P., Renner W., Yazdani-Biuki B., Eder T., Kцppel H., Wascher T.C., Paulweber B., Samonigg H. Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk//Breast Cancer Research and Treatment. -2005. -Vol. 90, N 2. -P. 113-115.</mixed-citation><mixed-citation xml:lang="en">Langsenlehner U., Kriрl P., Renner W., Yazdani-Biuki B., Eder T., Kцppel H., Wascher T.C., Paulweber B., Samonigg H. Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk//Breast Cancer Research and Treatment. -2005. -Vol. 90, N 2. -P. 113-115.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Mock C.C., Lanchbury J.S., Chan D.W., Lau C.S. Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus//Arthritis Rheum. -1998. -Vol. 41. -P. 1090-1095.</mixed-citation><mixed-citation xml:lang="en">Mock C.C., Lanchbury J.S., Chan D.W., Lau C.S. Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus//Arthritis Rheum. -1998. -Vol. 41. -P. 1090-1095.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Nagai S., Toi M. Interleukin-4 and breast cancer//Breast Cancer. -2000. -Vol. 7(3). -P. 181-186.</mixed-citation><mixed-citation xml:lang="en">Nagai S., Toi M. Interleukin-4 and breast cancer//Breast Cancer. -2000. -Vol. 7(3). -P. 181-186.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Nishimura R., Nagao K., Miyayama H.,Matsuda M., Baba K., Matsuoka Y.,Yamashita H.,Fukuda M.,Mizumoto T., Hamamoto R. An analysis of serum interleukin-6 levels to predict benefits of medroxyprogesterone acetate in advanced or recurrent breast cancer//Oncology. -2000. -Vol. 59. -P. 166-173.</mixed-citation><mixed-citation xml:lang="en">Nishimura R., Nagao K., Miyayama H.,Matsuda M., Baba K., Matsuoka Y.,Yamashita H.,Fukuda M.,Mizumoto T., Hamamoto R. An analysis of serum interleukin-6 levels to predict benefits of medroxyprogesterone acetate in advanced or recurrent breast cancer//Oncology. -2000. -Vol. 59. -P. 166-173.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Purohit A., Newman P.S., Reed M.J. The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer//Breast Cancer Res. -2002. -Vol. 4. -P. 65-69.</mixed-citation><mixed-citation xml:lang="en">Purohit A., Newman P.S., Reed M.J. The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer//Breast Cancer Res. -2002. -Vol. 4. -P. 65-69.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Slattery M.L., Curtin K., Baumgartner R., Sweeney C., Byers T., Giuliano A.R., Baumgartner K.B., Wolff R.R. IL-6, aspirin, nonsteroidal anti-inflammatory drugs, and breast cancer risk in women living in the southwestern United States//Cancer Epidemiol Biomarkers Prev. -2007. -Vol. 16, N 4. -P. 747-755.</mixed-citation><mixed-citation xml:lang="en">Slattery M.L., Curtin K., Baumgartner R., Sweeney C., Byers T., Giuliano A.R., Baumgartner K.B., Wolff R.R. IL-6, aspirin, nonsteroidal anti-inflammatory drugs, and breast cancer risk in women living in the southwestern United States//Cancer Epidemiol Biomarkers Prev. -2007. -Vol. 16, N 4. -P. 747-755.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Smith K.C., Bateman A.C., Fussell H.M., Howell W.M. Cytokine gene polymorphisms and breast cancer susceptibility and prognosis//European Journal of Immunogenetics. -2004. -Vol. 31, N 4. -P. 167-173.</mixed-citation><mixed-citation xml:lang="en">Smith K.C., Bateman A.C., Fussell H.M., Howell W.M. Cytokine gene polymorphisms and breast cancer susceptibility and prognosis//European Journal of Immunogenetics. -2004. -Vol. 31, N 4. -P. 167-173.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Vairaktaris E., Yannopoulos A., Vassiliou S., Serefoglou Z., Vylliotis A., Nkenke E., Critselis E. ,Avgoustidis D., Yapijakis C., Neukam F.W., Patsouris E. Strong association of interleukin-4 (-590 C/T) polymorphism with increased risk for oral squamous cell carcinoma in Europeans//Oral Surg Oral Med Oral Pathol Oral Radiol Endod. -2007. -Vol. 104, N 6. -P. 796-802.</mixed-citation><mixed-citation xml:lang="en">Vairaktaris E., Yannopoulos A., Vassiliou S., Serefoglou Z., Vylliotis A., Nkenke E., Critselis E. ,Avgoustidis D., Yapijakis C., Neukam F.W., Patsouris E. Strong association of interleukin-4 (-590 C/T) polymorphism with increased risk for oral squamous cell carcinoma in Europeans//Oral Surg Oral Med Oral Pathol Oral Radiol Endod. -2007. -Vol. 104, N 6. -P. 796-802.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Venetsanakos E., Beckman I., Bradley J., Skinner J.M. High incidence of interleukin-10 mRNA but not interleukin-2 mRNA detected in human breast tumours//Br. J. Cancer. -1997. -Vol. 75, N 12. -P. 1826-1830.</mixed-citation><mixed-citation xml:lang="en">Venetsanakos E., Beckman I., Bradley J., Skinner J.M. High incidence of interleukin-10 mRNA but not interleukin-2 mRNA detected in human breast tumours//Br. J. Cancer. -1997. -Vol. 75, N 12. -P. 1826-1830.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Yannopoulos A., Nikiteas N., Chatzit-heofylaktou A., Tsigris C. The (-590 C/T) polymorphism in the interleukin-4 gene is associated with increased risk for early stages of corolectal adenocarcinoma//In Vivo. -2007. -Vol. 21, N 6. -P. 1031-1035.</mixed-citation><mixed-citation xml:lang="en">Yannopoulos A., Nikiteas N., Chatzit-heofylaktou A., Tsigris C. The (-590 C/T) polymorphism in the interleukin-4 gene is associated with increased risk for early stages of corolectal adenocarcinoma//In Vivo. -2007. -Vol. 21, N 6. -P. 1031-1035.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Yokoe T., Iino Y., Morishita Y. Trends of IL-6 and IL-8 levels in patients with recurrent breast cancer: preliminary report//Breast Cancer. -2000. -Vol. 7. -P. 187-190.</mixed-citation><mixed-citation xml:lang="en">Yokoe T., Iino Y., Morishita Y. Trends of IL-6 and IL-8 levels in patients with recurrent breast cancer: preliminary report//Breast Cancer. -2000. -Vol. 7. -P. 187-190.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang G.J., Adachi I. Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma//Anticancer Res. -1999. -Vol. 19. -P. 1427-1432.</mixed-citation><mixed-citation xml:lang="en">Zhang G.J., Adachi I. Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma//Anticancer Res. -1999. -Vol. 19. -P. 1427-1432.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
